Earnings
China revenue in Q3 increased by 12 percent at AstraZeneca and the country now accounts for 15 percent of its global product sales.
The Company’s management will share its progress on various research and product development efforts over the past year.
Patrick Soon-Shiong touted sales of his closely scrutinized test without revealing the purchaser was on his payroll.
Strong balance sheet with $235.4 million of cash as of September 30, 2017 supports Company’s current clinical development plans and business development activities.
To access the live conference call via phone, dial 1-(844) 835-6563.
The Company will host a conference call and live webcast at 4:30 p.m. ET on the same day.
The Company will host a conference call to discuss these results and provide an update on all rigosertib programs at 9:00 a.m. ET.
Here are four players that have the right combination of elements to post an earnings beat this quarter.
Net product revenue in the third quarter of 2017 achieved record levels.
The company will host a conference call to provide a corporate update.
PRESS RELEASES